The DOI matches its Crossref record; 184 of the 184 references it cites were found in a registry or an index.
The Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition
Open accessAbstract
The formyl peptide receptors (FPRs) are G protein-coupled receptors that transduce chemotactic signals in phagocytes and mediate host-defense as well as inflammatory responses including cell adhesion, directed migration, granule release and superoxide production. In recent years, the cellular distribution and biological functions of FPRs have expanded to include additional roles in homeostasis of organ functions and modulation of inflammation. In a prototype, FPRs recognize peptides containing N-formylated methionine such as those produced in bacteria and mitochondria, thereby serving as pattern recognition receptors. The repertoire of FPR ligands, however, has expanded rapidly to include not only N-formyl peptides from microbes but also non-formyl peptides of microbial and host origins, synthetic small molecules and an eicosanoid. How these chemically diverse ligands are recognized by the three human FPRs (FPR1, FPR2 and FPR3) and their murine equivalents is largely unclear. In the absence of crystal structures for the FPRs, site-directed mutagenesis, computer-aided ligand docking and structural simulation have led to the identification of amino acids within FPR1 and FPR2 that interact with several formyl peptides. This review article summarizes the progress made in the understanding of FPR ligand diversity as well as ligand recognition mechanisms used by these receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,306
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., et al. (2000) · Science · doi:10.1126/science.289.5480.739 · Cited by 5,637
Circulating mitochondrial DAMPs cause inflammatory responses to injury
Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K., Itagaki, K., & Hauser, C. J. (2010) · Nature · doi:10.1038/nature08780 · Cited by 3,812
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
Bennett, L., Palucka, A. K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J., & Pascual, V. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021553 · Cited by 1,958
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
Wu, B., Chien, E. Y. T., Mol, C. D., Fenalti, G., Liu, W., Katritch, V., Abagyan, R., Brooun, A., Wells, P., Bi, F. C., et al. (2010) · Science · doi:10.1126/science.1194396 · Cited by 1,782
Yang, D., Chen, Q., Schmidt, A. P., Anderson, G. M., Wang, J. M., Wooters, J., Oppenheim, J. J., & Chertov, O. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1069 · Cited by 1,240
Intravascular Danger Signals Guide Neutrophils to Sites of Sterile Inflammation
McDonald, B., Pittman, K., Menezes, G. B., Hirota, S. A., Slaba, I., Waterhouse, C. C. M., Beck, P. L., Muruve, D. A., & Kubes, P. (2010) · Science · doi:10.1126/science.1195491 · Cited by 1,210
Th17 cell induction by adhesion of microbes to intestinal epithelial cells
Atarashi, K., Tanoue, T., Ando, M., Kamada, N., Nagano, Y., Narushima, S., Suda, W., Imaoka, A., Setoyama, H., Nagamori, T., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.058 · Cited by 1,071
Resolution of in flammation: state of the art, definitions and terms
Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A. J., Perretti, M., Rossi, A. G., & Wallace, J. L. (2007) · The FASEB Journal · doi:10.1096/fj.06-7227rev · Cited by 1,045 · cited 1×
“Lipoxin A4 (LXA4), derived from arachidonic acid, has highly potent anti-inflammatory and pro-resolving activities based on in vivo studies [149] [150] [151] [152] .”
BackgroundN-formylmethionyl peptides as chemoattractants for leucocytes.
Schiffmann, E., Corcoran, B. A., & Wahl, S. M. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.3.1059 · Cited by 881
An angiogenic role for the human peptide antibiotic LL-37/hCAP-18
Koczulla, R., von Degenfeld, G., Kupatt, C., Krötz, F., Zahler, S., Gloe, T., Issbrücker, K., Unterberger, P., Zaiou, M., Lebherz, C., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17545 · Cited by 863
Ye, R. D., Boulay, F., Wang, J. M., Dahlgren, C., Gerard, C., Parmentier, M., Serhan, C. N., & Murphy, P. M. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001578 · Cited by 764
Self-citationResolvin D1 binds human phagocytes with evidence for proresolving receptors
Krishnamoorthy, S., Recchiuti, A., Chiang, N., Yacoubian, S., Lee, C.-H., Yang, R., Petasis, N. A., & Serhan, C. N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907342107 · Cited by 730
Sano, T., Huang, W., Hall, J. A., Yang, Y., Chen, A., Gavzy, S. J., Lee, J.-Y., Ziel, J. W., Miraldi, E. R., Domingos, A. I., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.061 · Cited by 547
Marasco, W. A., Phan, S. H., Krutzsch, H., Showell, H. J., Feltner, D. E., Nairn, R., Becker, E. L., & Ward, P. A. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)91029-x · Cited by 521
Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor
Bokoch, M. P., Zou, Y., Rasmussen, S. G. F., Liu, C. W., Nygaard, R., Rosenbaum, D. M., Fung, J. J., Choi, H.-J., Thian, F. S., Kobilka, T. S., et al. (2010) · Nature · doi:10.1038/nature08650 · Cited by 470
The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo
Chiang, N., Serhan, C. N., Dahlén, S.-E., Drazen, J. M., Hay, D. W. P., Rovati, G. E., Shimizu, T., Yokomizo, T., & Brink, C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.4 · Cited by 464
MIGEOTTE, I., COMMUNI, D., & PARMENTIER, M. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.09.009 · Cited by 457
Serhan, C. N. (2005) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.002 · Cited by 454
Perretti, M., Chiang, N., La, M., Fierro, I. M., Marullo, S., Getting, S. J., Solito, E., & Serhan, C. N. (2002) · Nature Medicine · doi:10.1038/nm786 · Cited by 447
Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor.
Fiore, S., Maddox, J. F., Perez, H. D., & Serhan, C. N. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.253 · Cited by 436
Takano, T., Fiore, S., Maddox, J. F., Brady, H. R., Petasis, N. A., & Serhan, C. N. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1693 · Cited by 431
Su, S. B., Gong, W., Gao, J.-L., Shen, W., Murphy, P. M., Oppenheim, J. J., & Wang, J. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.395 · Cited by 429
Formyl peptide receptor-like proteins are a novel family of vomeronasal chemosensors
Rivière, S., Challet, L., Fluegge, D., Spehr, M., & Rodriguez, I. (2009) · Nature · doi:10.1038/nature08029 · Cited by 384
Community-associated MRSA: What makes them special?
Otto, M. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.02.007 · Cited by 379
Resnati, M., Pallavicini, I., Wang, J. M., Oppenheim, J., Serhan, C. N., Romano, M., & Blasi, F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022652999 · Cited by 360
Serum amyloid A induces IL-8 secretion through a G protein–coupled receptor, FPRL1/LXA4R
He, R., Sang, H., & Ye, R. D. (2003) · Blood · doi:10.1182/blood-2002-05-1431 · Cited by 329
Self-citationBoulay, F., Tardif, M., Brouchon, L., & Vignais, P. (1990) · Biochemistry · doi:10.1021/bi00502a016 · Cited by 322
Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils.
Carp, H. (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.1.264 · Cited by 316
Coffelt, S. B., Marini, F. C., Watson, K., Zwezdaryk, K. J., Dembinski, J. L., LaMarca, H. L., Tomchuck, S. L., zu Bentrup, K. H., Danka, E. S., Henkle, S. L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900244106 · Cited by 293
Human Formyl Peptide Receptor 2 Senses Highly Pathogenic Staphylococcus aureus
Kretschmer, D., Gleske, A.-K., Rautenberg, M., Wang, R., Köberle, M., Bohn, E., Schöneberg, T., Rabiet, M.-J., Boulay, F., Klebanoff, S. J., et al. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.05.012 · Cited by 282
Amyloid β42Activates a G-Protein-Coupled Chemoattractant Receptor, FPR-Like-1
Le, Y., Gong, W., Tiffany, H. L., Tumanov, A., Nedospasov, S., Shen, W., Dunlop, N. M., Gao, J.-L., Murphy, P. M., Oppenheim, J. J., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-j0003.2001 · Cited by 270
The Isolation and Partial Characterization of Neutrophil Chemotactic Factors from Escherichia Coli
Schiffmann, E., Showell, H. V., Corcoran, B. A., Ward, P. A., Smith, E., & Becker, E. L. (1975) · The Journal of Immunology · doi:10.4049/jimmunol.114.6.1831 · Cited by 269
Lipoxin A4: A New Class of Ligand for the Ah Receptor
Schaldach, C. M., Riby, J., & Bjeldanes, L. F. (1999) · Biochemistry · doi:10.1021/bi982861e · Cited by 264
Resolvin D1 and Resolvin D2 Govern Local Inflammatory Tone in Obese Fat
Clària, J., Dalli, J., Yacoubian, S., Gao, F., & Serhan, C. N. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201272 · Cited by 262
Impaired Antibacterial Host Defense in Mice Lacking the N-formylpeptide Receptor
Gao, J.-L., Lee, E. J., & Murphy, P. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.4.657 · Cited by 261
Chiang, N., Fierro, I. M., Gronert, K., & Serhan, C. N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1197 · Cited by 260
Boulay, F., Tardif, M., Brouchon, L., & Vignais, P. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91143-g · Cited by 256
Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure
Shaykhiev, R., Beißwenger, C., Kändler, K., Senske, J., Püchner, A., Damm, T., Behr, J., & Bals, R. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00286.2004 · Cited by 254
Formyl peptide receptors are candidate chemosensory receptors in the vomeronasal organ
Liberles, S. D., Horowitz, L. F., Kuang, D., Contos, J. J., Wilson, K. L., Siltberg-Liberles, J., Liberles, D. A., & Buck, L. B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904464106 · Cited by 246
Hayhoe, R. P. G., Kamal, A. M., Solito, E., Flower, R. J., Cooper, D., & Perretti, M. (2006) · Blood · doi:10.1182/blood-2005-08-3099 · Cited by 238
Postma, B., Poppelier, M. J., van Galen, J. C., Prossnitz, E. R., van Strijp, J. A. G., de Haas, C. J. C., & van Kessel, K. P. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6994 · Cited by 235
Further studies on the structural requirements for synthetic peptide chemoattractants
Freer, R. J., Day, A. R., Radding, J. A., Schiffmann, E., Aswanikumar, S., Showell, H. J., & Becker, E. L. (1980) · Biochemistry · doi:10.1021/bi00552a019 · Cited by 226
Kurosaka, K., Chen, Q., Yarovinsky, F., Oppenheim, J. J., & Yang, D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6257 · Cited by 222
Ying, G., Iribarren, P., Zhou, Y., Gong, W., Zhang, N., Yu, Z.-X., Le, Y., Cui, Y., & Wang, J. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.7078 · Cited by 219
Rabiet, M.-J., Huet, E., & Boulay, F. (2005) · European Journal of Immunology · doi:10.1002/eji.200526338 · Cited by 218
Murphy, P. M., Ozçelik, T., Kenney, R. T., Tiffany, H. L., McDermott, D., & Francke, U. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42563-x · Cited by 203
Christophe, T., Karlsson, A., Dugave, C., Rabiet, M.-J., Boulay, F., & Dahlgren, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007769200 · Cited by 202
Pleiotropic roles of formyl peptide receptors
LE, Y., OPPENHEIM, J., & WANG, J. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00003-x · Cited by 192
Le, Y., Gong, W., Li, B., Dunlop, N. M., Shen, W., Su, S. B., Ye, R. D., & Wang, J. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6777 · Cited by 182
Self-citationEickmeier, O., Seki, H., Haworth, O., Hilberath, J. N., Gao, F., Uddin, M., Croze, R. H., Carlo, T., Pfeffer, M. A., & Levy, B. D. (2013) · Mucosal Immunology · doi:10.1038/mi.2012.66 · Cited by 182
Anti-inflammatory lipoxin A 4 is an endogenous allosteric enhancer of CB 1 cannabinoid receptor
Pamplona, F. A., Ferreira, J., Menezes de Lima, O., Duarte, F. S., Bento, A. F., Forner, S., Villarinho, J. G., Bellocchio, L., Wotjak, C. T., Lerner, R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202906109 · Cited by 179
Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis
Lu, J., Yu, Y., Zhu, I., Cheng, Y., & Sun, P. D. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322357111 · Cited by 177
Bao, L., Gerard, N. P., Eddy, R. L., Shows, T. B., & Gerard, C. (1992) · Genomics · doi:10.1016/0888-7543(92)90265-t · Cited by 172
Distinct Signaling Cascades Elicited by Different Formyl Peptide Receptor 2 (FPR2) Agonists
Cattaneo, F., Parisi, M., & Ammendola, R. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14047193 · Cited by 168
Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor
Ye, R. D., Cavanagh, S. L., Quehenberger, O., Prossnitz, E. R., & Cochrane, C. G. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90629-y · Cited by 168
Self-citationIdentification of Peptides That Antagonize Formyl Peptide Receptor-Like 1-Mediated Signaling
Bae, Y.-S., Lee, H. Y., Jo, E. J., Kim, J. I., Kang, H.-K., Ye, R. D., Kwak, J.-Y., & Ryu, S. H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.607 · Cited by 165
Self-citationErnst, S., Lange, C., Wilbers, A., Goebeler, V., Gerke, V., & Rescher, U. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7669 · Cited by 164
Bozinovski, S., Uddin, M., Vlahos, R., Thompson, M., McQualter, J. L., Merritt, A.-S., Wark, P. A. B., Hutchinson, A., Irving, L. B., Levy, B. D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109382109 · Cited by 163
Tiffany, H. L., Lavigne, M. C., Cui, Y., Wang, J., Leto, T. L., Gao, J., & Murphy, P. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101031200 · Cited by 161
O’Callaghan, K., Kuliopulos, A., & Covic, L. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.355461 · Cited by 159
Identification of surrogate agonists for the human FPRL-1 receptor by autocrine selection in yeast
Klein, C., Paul, J. I., Sauvé, K., Schmidt, M. M., Arcangeli, L., Ransom, J. T., Trueheart, J., Manfredi, J. P., Broach, J. R., & Murphy, A. J. (1998) · Nature Biotechnology · doi:10.1038/4310 · Cited by 150
Annexin A1 Interaction with the FPR2/ALX Receptor
Bena, S., Brancaleone, V., Wang, J. M., Perretti, M., & Flower, R. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.377101 · Cited by 150
O’Hara, R., Murphy, E. P., Whitehead, A. S., FitzGerald, O., & Bresnihan, B. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20301 · Cited by 149
Dahlgren, C., Gabl, M., Holdfeldt, A., Winther, M., & Forsman, H. F. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.04.014 · Cited by 147
Liu, M., Chen, K., Yoshimura, T., Liu, Y., Gong, W., Wang, A., Gao, J., Murphy, P. M., & Wang, J. M. (2012) · Scientific Reports · doi:10.1038/srep00786 · Cited by 145
A New Staphylococcal Anti-Inflammatory Protein That Antagonizes the Formyl Peptide Receptor-Like 1
Prat, C., Bestebroer, J., de Haas, C. J. C., van Strijp, J. A. G., & van Kessel, K. P. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.8017 · Cited by 137
Betten, Å., Bylund, J., Cristophe, T., Boulay, F., Romero, A. I., Hellstrand, K., & Dahlgren, C. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13430 · Cited by 136
Stenfeldt, A., Karlsson, J., Wennerås, C., Bylund, J., Fu, H., & Dahlgren, C. (2007) · Inflammation · doi:10.1007/s10753-007-9040-4 · Cited by 134
Le, Y., Yazawa, H., Gong, W., Yu, Z., Ferrans, V. J., Murphy, P. M., & Wang, J. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.1448 · Cited by 133
Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents
Bürli, R. W., Xu, H., Zou, X., Muller, K. M., Golden, J. E., Frohn, M., Adlam, M. J., Plant, M., Wong, M., McElvain, M. E., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.04.068 · Cited by 125
N-Formylated humanin activates both formyl peptide receptor-like 1 and 2
Harada, M., Habata, Y., Hosoya, M., Nishi, K., Fujii, R., Kobayashi, M., & Hinuma, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.046 · Cited by 124
Identification and characterization of an endogenous chemotactic ligand specific for FPRL2
Migeotte, I., Riboldi, E., Franssen, J., Grégoire, F., Loison, C., Wittamer, V., Detheux, M., Robberecht, P., Costagliola, S., Vassart, G., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041277 · Cited by 123
Quehenberger, O., Prossnitz, E. R., Cavanagh, S. L., Cochrane, C. G., & Ye, R. D. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46825-6 · Cited by 122
Self-citationGao, J. L., & Murphy, P. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74405-6 · Cited by 122
Deng, X., Ueda, H., Su, S. B., Gong, W., Dunlop, N. M., Gao, J., Murphy, P. M., & Wang, J. (1999) · Blood · doi:10.1182/blood.v94.4.1165 · Cited by 121
Southgate, E. L., He, R. L., Gao, J., Murphy, P. M., Nanamori, M., & Ye, R. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.1429 · Cited by 117
Self-citationWenzel‐Seifert, K., & Seifert, R. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.10.4591 · Cited by 115
Cui, Y., Le, Y., Gong, W., Proost, P., Damme, J. V., Murphy, W. J., & Wang, J. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.1.434 · Cited by 112
Formyl peptide receptors at the interface of inflammation, angiogenesis and tumor growth
Prevete, N., Liotti, F., Marone, G., Melillo, R. M., & de Paulis, A. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.09.017 · Cited by 112
de Paulis, A., Montuori, N., Prevete, N., Fiorentino, I., Rossi, F. W., Visconte, V., Rossi, G., Marone, G., & Ragno, P. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5739 · Cited by 109
Iribarren, P., Zhou, Y., Hu, J., Le, Y., & Wang, J. M. (2005) · Immunologic Research · doi:10.1385/ir:31:3:165 · Cited by 108
YAZAWA, H., YU, Z.-X., TAKEDA, K., LE, Y., GONG, W., FERRANS, V. J., OPPENHEIM, J. J., LI, C. C. H., & WANG, J. M. (2001) · The FASEB Journal · doi:10.1096/fj.01-0251com · Cited by 105
Hartt, J. K., Barish, G. D., Murphy, P. M., & Gao, J. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.5.741 · Cited by 104
Seo, J. K., Choi, S., Kim, Y. D., Baek, S., Kim, K., Chae, C. B., Lambeth, J. D., Suh, P., & Ryu, S. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.4.1895 · Cited by 102
Edwards, B. S., Bologa, C., Young, S. M., Balakin, K. V., Prossnitz, E. R., Savchuk, N., Sklar, L. A., & Oprea, T. I. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.014068 · Cited by 102
Su, S. B., Gao, J., Gong, W.-H., Dunlop, N. M., Murphy, P. M., Oppenheim, J. J., & Wang, J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.5924 · Cited by 95
Liang, T. S., Wang, J., Murphy, P. M., & Gao, J. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2416 · Cited by 95
Linking agonist binding to histamine H1 receptor activation
Jongejan, A., Bruysters, M. W. P., Ballesteros, J. A., Haaksma, E. E. J., Bakker, R. A., Pardo, L., & Leurs, R. (2005) · Nature Chemical Biology · doi:10.1038/nchembio714 · Cited by 95
Wan, M., Godson, C., Guiry, P. J., Agerberth, B., & Haeggström, J. Z. (2011) · The FASEB Journal · doi:10.1096/fj.10-175687 · Cited by 95
Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1
Hu, J. Y., Le, Y., Gong, W., Dunlop, N. M., Gao, J. L., Murphy, P. M., & Wang, J. M. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.1.155 · Cited by 94
Haas, P., de Haas, C. J. C., Kleibeuker, W., Poppelier, M. J. J. G., van Kessel, K. P. M., Kruijtzer, J. A. W., Liskamp, R. M. J., & van Strijp, J. A. G. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5704 · Cited by 93
Resolvin D1 prevents TNF-α-mediated disruption of salivary epithelial formation
Odusanwo, O., Chinthamani, S., McCall, A. D., Duffey, M. E., & Baker, O. J. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00207.2011 · Cited by 93
Rittner, H. L., Hackel, D., Voigt, P., Mousa, S. A., Stolz, A., Łabuz, D., Schäfer, M., Schäfer, M., Stein, C., & Brack, A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000362 · Cited by 91
Coffelt, S. B., Tomchuck, S. L., Zwezdaryk, K. J., Danka, E. S., & Scandurro, A. B. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0326 · Cited by 86
Sodin-Semrl, S., Spagnolo, A., Mikus, R., Barbaro, B., Varga, J., & Fiore, S. (2004) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200401700206 · Cited by 82
Anton, P. A., Targan, S. R., & Shanahan, F. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)91410-8 · Cited by 80
Defective polymorphonuclear leukocyte formyl peptide receptor(s) in juvenile periodontitis.
Perez, H. D., Kelly, E. J., Elfman, F., et al. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115105 · Cited by 79
Cui, Y., Le, Y., Yazawa, H., Gong, W., & Wang, J. M. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.4.628 · Cited by 79
Su, S. B., Gong, W.-H., Gao, J., Shen, W.-P., Grimm, M., Deng, X., Murphy, P. M., Oppenheim, J. J., & Wang, J. (1999) · Blood · doi:10.1182/blood.v93.11.3885.411k19_3885_3892 · Cited by 77
A Novel Nonpeptide Ligand for Formyl Peptide Receptor-Like 1
Nanamori, M., Cheng, X., Mei, J., Sang, H., Xuan, Y., Zhou, C., Wang, M.-W., & Ye, R. D. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.004309 · Cited by 76
Self-citationLipoxin A 4 is a novel estrogen receptor modulator
Russell, R., Gori, I., Pellegrini, C., Kumar, R., Achtari, C., & Canny, G. (2011) · The FASEB Journal · doi:10.1096/fj.11-187658 · Cited by 72
Young, S. M., Bologa, C., Prossnitz, E. R., Oprea, T. I., Sklar, L. A., & Edwards, B. S. (2005) · SLAS DISCOVERY · doi:10.1177/1087057105274532 · Cited by 72
New development in studies of formyl-peptide receptors: critical roles in host defense
Li, L., Chen, K., Xiang, Y., Yoshimura, T., Su, S., Zhu, J., Bian, X., & Wang, J. M. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.2ri0815-354rr · Cited by 72
Cheung, G. Y. C., Kretschmer, D., Queck, S. Y., Joo, H., Wang, R., Duong, A. C., Nguyen, T. D., Bach, T. L., Porter, A. R., DeLeo, F. R., et al. (2013) · The FASEB Journal · doi:10.1096/fj.13-232041 · Cited by 69
Schepetkin, I. A., Kirpotina, L. N., Khlebnikov, А. I., & Quinn, M. T. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.033100 · Cited by 67
de Paulis, A., Prevete, N., Fiorentino, I., Walls, A. F., Curto, M., Petraroli, A., Castaldo, V., Ceppa, P., Fiocca, R., & Marone, G. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7734 · Cited by 66
Genetic Ablation of the Fpr1 Gene Confers Protection from Smoking-Induced Lung Emphysema in Mice
Cardini, S., Dalli, J., Fineschi, S., Perretti, M., Lungarella, G., & Lucattelli, M. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0036oc · Cited by 66
Björkman, L. I., Karlsson, J., Karlsson, A., Rabiet, M., Boulay, F., Fu, H., Bylund, J., & Dahlgren, C. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0607-408 · Cited by 66
Functional Characterization of Three Mouse Formyl Peptide Receptors
He, H.-Q., Liao, D., Wang, Z.-G., Wang, Z.-L., Zhou, H.-C., Wang, M.-W., & Ye, R. D. (2013) · Molecular Pharmacology · doi:10.1124/mol.112.081315 · Cited by 65
Self-citationHwang, T., Wang, C.-C., Kuo, Y., Huang, H., Wu, Y., Kuo, L.-M., & Wu, Y.-H. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.028 · Cited by 65
Structural Determinants for the Interaction of Formyl Peptide Receptor 2 with Peptide Ligands
He, H.-Q., Troksa, E. L., Caltabiano, G., Pardo, L., & Ye, R. D. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.509216 · Cited by 64
Self-citationForsman, H. F., Christenson, K., Bylund, J., & Dahlgren, C. (2012) · Infection and Immunity · doi:10.1128/iai.05906-11 · Cited by 62
Dahinden, C. A., & Fehr, J. S. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109955 · Cited by 59
Shen, W., Proost, P., Li, B., Gong, W., Le, Y., Sargeant, R., Murphy, P. M., Damme, J. V., & Wang, J. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2770 · Cited by 59
Derian, C. K., Solomon, H. F., Higgins, J. D., Beblavy, M. J., Santulli, R. J., Bridger, G. J., Pike, M. C., Kroon, D. J., & Fischman, A. J. (1996) · Biochemistry · doi:10.1021/bi952087k · Cited by 59
Hecht, I., Rong, J., Sampaio, A. L. F., Hermesh, C., Rutledge, C., Shemesh, R., Toporik, A., Beiman, M., Dassa, L., Niv, H., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.145821 · Cited by 58
Christenson, K., Björkman, L. I., Ahlin, S., Olsson, M. M., Sjöholm, K., Karlsson, A., & Bylund, J. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00092 · Cited by 57
Le, Y., Jiang, S.-B., Hu, J.-Y., Gong, W., Su, S., Dunlop, N., Shen, W.-P., Li, B.-Q., & Wang, J.-M. (2000) · Clinical Immunology · doi:10.1006/clim.2000.4896 · Cited by 56
MILLS, J. S., Miettinen, H. M., Cummings, D. F., & Jesaitis, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003081200 · Cited by 56
Schepetkin, I. A., Khlebnikov, А. I., Giovannoni, M. P., Kirpotina, L. N., Cilibrizzi, A., & Quinn, M. T. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666131218095521 · Cited by 54
Chen, M., Zhou, H., Cheng, N., Qian, F., & Ye, R. D. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.08.002 · Cited by 54
Self-citationIdentification of FAM3D as a new endogenous chemotaxis agonist for the formyl peptide receptors
Peng, X., Xu, E., Liang, W., Pei, X., Chen, D., Zheng, D., Zhang, Y., Zheng, C., Wang, P., She, S., et al. (2016) · Journal of Cell Science · doi:10.1242/jcs.183053 · Cited by 52
Heterologously expressed formyl peptide receptor 2 (FPR2/ALX) does not respond to lipoxin A4
Hanson, J., Ferreirós, N., Pirotte, B., Geißlinger, G., & Offermanns, S. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.04.019 · Cited by 51
Honda, M., Takeichi, T., Hashimoto, S., Yoshii, D., Isono, K., Hayashida, S., Ohya, Y., Yamamoto, H., Sugawara, Y., & Inomata, Y. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601773 · Cited by 51
Vaughn, M. W., Proske, R. J., & Haviland, D. L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3363 · Cited by 50
Kang, H. K., Lee, H., Kim, M.-K., Park, K. S., Park, Y. M., Kwak, J., & Bae, Y. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.685 · Cited by 48
Giovannoni, M. P., Schepetkin, I. A., Cilibrizzi, A., Crocetti, L., Khlebnikov, А. I., Dahlgren, C., Graziano, A., Piaz, V. D., Kirpotina, L. N., Zerbinati, S., et al. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.03.066 · Cited by 48
What Formyl Peptide Receptors, if Any, Are Triggered by Compound 43 and Lipoxin A4?
Forsman, H. F., Önnheim, K., Andréasson, E., & Dahlgren, C. (2011) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2011.02570.x · Cited by 46
Karlsson, J., Fu, H., Boulay, F., Dahlgren, C., Hellstrand, K., & Movitz, C. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0305153 · Cited by 44
Cloning of a cDNA encoding a receptor related to the formyl peptide receptor of human neutrophils
Perez, H. D., Holmes, R., Kelly, E., McClary, J., & Andrews, W. H. (1992) · Gene · doi:10.1016/0378-1119(92)90208-7 · Cited by 43
Characterization of two new members of the formyl peptide receptor gene family from 129S6 mice
Wang, Z.-G., & Ye, R. D. (2002) · Gene · doi:10.1016/s0378-1119(02)01012-0 · Cited by 43
Self-citationMadenspacher, J. H., Azzam, K. M., Gong, W., Gowdy, K. M., Vitek, M. P., Laskowitz, D. T., Remaley, A. T., Wang, J. M., & Fessler, M. B. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.377192 · Cited by 42
He, M., Cheng, N., Gao, W.-W., Zhang, M., Zhang, Y.-Y., Ye, R. D., & Wang, M.-W. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.4 · Cited by 42
Self-citationInsider access: pepducin symposium explores a new approach to GPCR modulation
Miller, J. B., Agarwal, A., Devi, L. A., Brunaldi, K., Hamilton, J. A., Pin, J., Shields, D. C., Spek, C. A., Sakmar, T. P., Kuliopulos, A., et al. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05326.x · Cited by 40
Le, Y., Ye, R. D., Gong, W., Li, J., Iribarren, P., & Wang, J. M. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2004.04514.x · Cited by 39
Self-citationForsman, H. F., Winther, M., Gabl, M., Skovbakke, S. L., Boulay, F., Rabiet, M., & Dahlgren, C. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.10.021 · Cited by 39
FPRL1-mediated induction of superoxide in LL-37-stimulated IMR90 human fibroblast
Iaccio, A., Cattaneo, F., Mauro, M., & Ammendola, R. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.10.026 · Cited by 38
Movitz, C., Brive, L., Hellstrand, K., Rabiet, M., & Dahlgren, C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.080465 · Cited by 38
Forsman, H. F., & Dahlgren, C. (2009) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2009.02311.x · Cited by 37
Pharmacophore model for bile acids recognition by the FPR receptor
Ferrari, C., Macchiarulo, A., Costantino, G., & Pellicciari, R. (2006) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-006-9055-1 · Cited by 37
Zein, N. E., Badran, B. M., & Sariban, E. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0507327 · Cited by 37
Hartt, J. K., Liang, T. S., Sahagún-Ruiz, A., Wang, J., Gao, J., & Murphy, P. M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2846 · Cited by 37
Loor, F., Tiberghien, F., Wenandy, T., Didier, A., & Traber, R. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010987v · Cited by 37
Kretschmer, D., Rautenberg, M., Linke, D., & Peschel, A. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.2a0514-275r · Cited by 36
Edwards, B. S., Young, S. M., Oprea, T. I., Bologa, C., Prossnitz, E. R., & Sklar, L. A. (2006) · Nature Protocols · doi:10.1038/nprot.2006.9 · Cited by 36
Schepetkin, I. A., Kirpotina, L. N., Khlebnikov, А. I., Jutila, M. A., & Quinn, M. T. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.068288 · Cited by 35
Pinilla, C., Edwards, B. S., Appel, J. R., Yates-Gibbins, T., Giulianotti, M. A., Medina‐Franco, J. L., Young, S. M., Santos, R. G., Sklar, L. A., & Houghten, R. A. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.086595 · Cited by 35
Liang, T. S., Gao, J., Fatemi, O., Lavigne, M. C., Leto, T. L., & Murphy, P. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6609 · Cited by 34
Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives
Schepetkin, I. A., Khlebnikov, А. I., Kirpotina, L. N., & Quinn, M. T. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.08.036 · Cited by 34
Forsman, H. F., Kalderén, C., Nordin, A., Nordling, E., Jensen, A. J., & Dahlgren, C. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.11.005 · Cited by 33
Activation of human monocytes by a formyl peptide receptor 2‐derived pepducin
Lee, H. Y., Kim, S. D., Shim, J. W., Kim, H. J., Kwon, J. Y., Kim, J., Baek, S., Park, J. S., & Bae, Y. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.08.036 · Cited by 32
Li, M., Chen, Q., Tang, R.-C., Shen, Y., & Liu, W. D. (2010) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2010.11.009 · Cited by 32
Cilibrizzi, A., Schepetkin, I. A., Bartolucci, G., Crocetti, L., Piaz, V. D., Giovannoni, M. P., Graziano, A., Kirpotina, L. N., Quinn, M. T., & Vergelli, C. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.04.043 · Cited by 31
High-Content Screening: Flow Cytometry Analysis
Edwards, B. S., Young, S. M., Ivnitski‐Steele, I. D., Ye, R. D., Prossnitz, E. R., & Sklar, L. A. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-545-3_11 · Cited by 30
Self-citationIdentification of anN-Formyl Peptide Receptor Ligand Binding Domain by a Gain-of-Function Approach
Quehenberger, O., Pan, Z. K., Prossnitz, E. R., Cavanagh, S. L., Cochrane, C. G., & Ye, R. D. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7298 · Cited by 30
Self-citationYamamoto, Y., Kanazawa, T., Shimamura, M., Ueki, M., & Hazato, T. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00221-9 · Cited by 30
Two Trypanocidal Dipeptides from the Roots of Zapoteca portoricensis (Fabaceae)
Nwodo, N., Okoye, F. B. C., Lai, D., Debbab, A., Brun, R., & Proksch, P. (2014) · Molecules · doi:10.3390/molecules19055470 · Cited by 30
Gabl, M., Winther, M., Skovbakke, S. L., Bylund, J., Dahlgren, C., & Forsman, H. F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109516 · Cited by 29
Schepetkin, I. A., Kirpotina, L. N., Tian, J., Khlebnikov, А. I., Ye, R. D., & Quinn, M. T. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.046946 · Cited by 28
Self-citationSeki, T., Fukamizu, A., Kiso, Y., & Mukai, H. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.12.007 · Cited by 28
Ray, R., Zhang, Z., Lee, Y., Gao, J., & Mukherjee, A. B. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.09.059 · Cited by 26
Adaptive Evolution of Formyl Peptide Receptors in Mammals
Muto, Y., Guindon, S., Umemura, T., et al. (2015) · Journal of Molecular Evolution · doi:10.1007/s00239-015-9666-z · Cited by 26
Lipoxins: update and impact of endogenous pro-resolution lipid mediators
O'Meara, S. J., Rodgers, K., & Godson, C. (2007) · Springer eBooks · doi:10.1007/112_2006_0606 · Cited by 25
Crocetti, L., Vergelli, C., Cilibrizzi, A., Graziano, A., Khlebnikov, А. I., Kirpotina, L. N., Schepetkin, I. A., Quinn, M. T., & Giovannoni, M. P. (2013) · Drug Development Research · doi:10.1002/ddr.21076 · Cited by 24
Yuan, S., Ghoshdastider, U., Trzaskowski, B., Latek, D., Dębiński, A., Puławski, W., Wu, R., Gerke, V., & Filipek, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047114 · Cited by 24
Reduced Fear Memory and Anxiety-like Behavior in Mice Lacking Formylpeptide Receptor 1
Gao, J., Schneider, E. H., Dimitrov, E. L., Haun, F., Pham, T. M., Mohammed, A. H. S., Usdin, T. B., & Murphy, P. M. (2011) · Behavior Genetics · doi:10.1007/s10519-011-9467-0 · Cited by 24
Trp-Arg-Trp-Trp-Trp-Trp antagonizes formyl peptide receptor like 2-mediated signaling
Shin, E. H., Lee, H., Kim, S. D., Jo, S. H., Kim, M.-K., Park, K. S., Lee, H., & Bae, Y. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.01.098 · Cited by 24
Lee, H. Y., Jo, S. H., Lee, C., Baek, S., & Bae, Y. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.022 · Cited by 23
MILLS, J. S. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.05.008 · Cited by 23
Mader, D., Rabiet, M., Boulay, F., & Peschel, A. (2010) · Microbes and Infection · doi:10.1016/j.micinf.2010.01.014 · Cited by 22
Skovbakke, S. L., Heegaard, P. M. H., Larsen, C. J., Franzyk, H., Forsman, H. F., & Dahlgren, C. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.11.004 · Cited by 22
Stępniewski, T. M., & Filipek, S. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.03.062 · Cited by 20
Khlebnikov, А. I., Schepetkin, I. A., Kirpotina, L. N., Brive, L., Dahlgren, C., Jutila, M. A., & Quinn, M. T. (2011) · Journal of Molecular Modeling · doi:10.1007/s00894-011-1307-x · Cited by 20
Lee, H. Y., Oh, E., Kim, S. D., Seo, J. K., & Bae, Y. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.12.082 · Cited by 19
Park, Y. J., Lee, S. K., Jung, Y. S., Lee, M., Lee, H. Y., Kim, S. D., Park, J. S., Koo, J., Hwang, J. S., & Bae, Y. (2016) · BMB Reports · doi:10.5483/bmbrep.2016.49.9.098 · Cited by 19
Gabl, M., Holdfeldt, A., Winther, M., Oprea, T. I., Bylund, J., Dahlgren, C., & Forsman, H. F. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.03.014 · Cited by 18
Human formyl peptide receptor function
Lala, A., Gwinn, M. R., & Nardin, E. D. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00647.x · Cited by 17
Lacivita, E., Schepetkin, I. A., Stama, M. L., Kirpotina, L. N., Colabufo, N. A., Perrone, R., Khlebnikov, А. I., Quinn, M. T., & Leopoldo, M. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.12.007 · Cited by 17
Oostendorp, R. A. J., Knol, E. F., Verhoeven, A. J., & Scheper, R. J. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.3.1010 · Cited by 14
Colucci, M., Mastriota, M., Μaione, F., Giannuario, A. D., Mascolo, N., Palmery, M., Severini, C., Perretti, M., & Pieretti, S. (2010) · Peptides · doi:10.1016/j.peptides.2010.11.019 · Cited by 12
Design, Synthesis and Characterization of fMLF‐Mimicking AApeptides
Hu, Y., Cheng, N., Wu, H., Kang, S., Ye, R. D., & Cai, J. (2014) · ChemBioChem · doi:10.1002/cbic.201402396 · Cited by 10
Self-citationHuang, Y., Chen, I., Tseng, C., Day, Y., Lin, Y., & Liao, C. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.10.002 · Cited by 9
Leukocyte chemoattractant receptor FPR2 may accelerate atherogenesis
Wan, W., & Gao, J. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.04.014 · Cited by 5
Cited by
The principles of directed cell migration
SenGupta, S., Parent, C. A., & Bear, J. E. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00366-6 · Cited by 669
Dendritic cell biology and its role in tumor immunotherapy
Wang, Y., Xiang, Y., Xin, V. W., Wang, X.-W., Peng, X.-C., Liu, X.-Q., Wang, D., Li, N., Cheng, J.-T., Lyv, Y.-N., et al. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00939-6 · Cited by 453
Brestoff, J. R., Wilen, C. B., Moley, J. R., Li, Y., Zou, W., Malvin, N. P., Rowen, M. N., Saunders, B. T., Ma, H., Mack, M. R., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.11.008 · Cited by 397
The interplay between vitamin D and viral infections
Teymoori‐Rad, M., Shokri, F., Salimi, V., & Marashi, S. M. (2019) · Reviews in Medical Virology · doi:10.1002/rmv.2032 · Cited by 279
Dela Cruz, C. S., & Kang, M.-J. (2018) · Mitochondrion · doi:10.1016/j.mito.2017.12.001 · Cited by 255
“FPRs constitute a small group of 7-transmembrane domain, G-protein-coupled receptors that are expressed not only on neutrophils, monocytes and dendritic cells but also on hepatocytes, endothelial cells and cells of the nervous system (He and Ye, 2017).”
Metadata
- Authors
- He, H.-Q., & Ye, R.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2017-03-13
- Volume
- 22
- Issue
- 3
- Pages
- 455
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2595655718
- Cited by
- 279
- References
- 184
- FWCI
- 8.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.